CellCentric (UK) Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $32.5M
Latest Deal Amount
  • Investors
  • 12

CellCentric (UK) General Information

Description

Developer of novel drugs designed to treat cancer. The company's platform offers drugs are small-molecule inhibitors that targets a deubiquitinase enzyme associated with prostate cancer, enabling physicians to treat cancer efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • Chesterford Research Park
  • Little Chesterford
  • Cambridge CB10 1XL
  • England, United Kingdom
+44 01799 000000

CellCentric (UK) Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CellCentric (UK) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Later Stage VC 22-Oct-2020 $32.5M 000.00 00000 Completed Generating Revenue
15. Later Stage VC 15-May-2018 000.00 000.00 000.00 Completed Generating Revenue
14. Later Stage VC 19-Jun-2017 00.000 000.00 000.00 Completed Generating Revenue
13. Grant 08-Nov-2016 000.00 Completed Generating Revenue
12. Later Stage VC 28-Jul-2016 00.000 000.00 000.00 Completed Generating Revenue
11. Later Stage VC 25-Jun-2013 00.000 000.00 Completed Generating Revenue
10. Later Stage VC (Series B) 14-Mar-2011 00.000 000.00 000.00 Completed Generating Revenue
9. Grant 03-Jun-2010 00.000 000.00 Completed Generating Revenue
8. Early Stage VC 25-Nov-2008 $2M $13.7M 0000 Completed Generating Revenue
7. Early Stage VC (Series A) 02-Oct-2007 $8.7M $11.7M 000.00 Completed Generating Revenue
To view CellCentric (UK)’s complete valuation and funding history, request access »

CellCentric (UK) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
A Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
A Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 0.00
A Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
A Ordinary 1,482,749 $0.001291 $8.73 $8.73 1x $8.73 4.14%
Ordinary 2,958 $0.001291 $8.73 $8.73 1x $8.73 0.01%
To view CellCentric (UK)’s complete cap table history, request access »

CellCentric (UK) Executive Team (7)

Name Title Board Seat Contact Info
William West Ph.D Co-Founder, Chief Executive Officer & Chairman
Thea Stanway Finance Director & Company Secretary
Neil Pegg Ph.D Research Director & Board Member
Azim Surani Co-Founder
You’re viewing 4 of 7 executive team members. Get the full list »

CellCentric (UK) Board Members (5)

Name Representing Role Since
Jason Dinges Ph.D Self Investor Director & Board Member 000 0000
Neil Pegg Ph.D CellCentric (UK) Research Director & Board Member 000 0000
William West Ph.D CellCentric (UK) Co-Founder, Chief Executive Officer & Chairman 000 0000
You’re viewing 3 of 5 board members. Get the full list »

CellCentric (UK) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CellCentric (UK) Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Morningside Group Venture Capital Minority 000 0000 000000 0
UK Innovation & Science Seed Fund Venture Capital Minority 000 0000 000000 0
Cambridge Enterprise Angel Group Minority 000 0000 000000 0
Innovate UK Government Minority 000 0000 000000 0
Takeda Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »